ArticleTropical medicine and health2026
Heterogeneous co-circulation of multiple DENV-1 and DENV-2 genotypes in Vung Tau during the 2023 dengue outbreak in Vietnam.
Article in Tropical medicine and health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
17 authors.
Funding
Abstract
Dengue virus (DENV) remains a significant global health threat, particularly in hyper-endemic regions like Vietnam, where the co-circulation of multiple serotypes and genotypes complicates disease control. In 2023, 6.5 million dengue cases and 6,800 deaths were reported globally, marking the largest dengue outbreak in the world. Vietnam recorded 149,557 dengue cases and 36 deaths, with a notable dominance of the DENV-2 serotype. This study provides a comprehensive genomic characterization of the 2023 outbreak using isolates collected from hospitalized patients (n = 148; 66.89% adults). To ensure robust viral recovery, we propagated 90 isolates using a low-passage, antibody-dependent enhancement (ADE)-based system. Whole-genome sequencing (WGS) of 53 isolates yielded 47 consensus sequences, including 26 complete genomes. Phylogenetic analysis revealed the simultaneous co-circulation of diverse DENV-1 and DENV-2 genotypes. DENV-1 isolates were predominantly genotype I (86%), clustering closely with prior Vietnamese strains and suggesting sustained endemic maintenance, while genotype IV (14%) was detected sporadically. Among DENV-2 isolates, the Cosmopolitan genotype was predominant (98%), with a smaller proportion (2%) belonging to the Asian 1 genotype. Both genotypes clustered with previously reported Vietnamese and regional Southeast Asian strains, indicating ongoing local circulation and regional viral exchange. Comparative mutational analysis of DENV-2 Cosmopolitan isolates identified multiple non-synonymous amino acid substitutions across the viral genome. Fourteen substitutions were shared between Vietnamese historical (2019-2022) and 2023 isolates, while 24 substitutions were unique to the 2023 outbreak strains. The majority of amino acid changes were concentrated within the NS5, E, NS1, and NS3 proteins, suggesting continued genetic diversification within the circulating Cosmopolitan lineage. Overall, these findings demonstrate the persistence of established DENV lineages alongside ongoing viral evolution during the 2023 outbreak in Vietnam. This study highlights the value of whole-genome surveillance for monitoring dengue virus genetic diversity and provides insight that may support future epidemiological surveillance, vaccine evaluation, and outbreak preparedness.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.